Robin joined Charnwood Molecular in December 2014 as Director of Business Development. An inventor on 6 patents and author of 25 publications to date, Robin is a results-focused individual, who has been responsible for Charnwood Molecular’s significant commercial growth globally since joining the company.


Robin holds a PhD in organic chemistry from the University of Liverpool and has >25 years of experience in the chemical industry. Robin has held a variety of roles covering technical and commercial aspects, with both drug discovery and development emphasis.


Robin’s technical achievements include contributing to IND candidates whilst in oncology drug discovery with OSI Pharmaceuticals, and achieving milestones for the advancement of drug candidates to clinical trials across a range of therapeutic areas whilst within contract research environments for companies including Evotec and Sygnature Discovery.